Maria D. Arranz-Martin

La Paz, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 125 publications

Position paper of the Spanish Society of Gastroenterology. Executive summary of the review of the Gastroenterology specialty strategic analysis. 2026-2030.

Position paper of the Spanish Society of Gastroenterology. Executive summary of the review of the Gastroenterology specialty strategic analysis. 2026-2030.

Journal: Revista espanola de enfermedades digestivas

Published: July 21, 2026

Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.

Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.

Journal: Alimentary pharmacology & therapeutics

Published: March 28, 2026

Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study.

Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study.

Journal: Alimentary pharmacology & therapeutics

Published: March 14, 2026

Time trends in strategies for postoperative Crohn's disease management and long-term surgical recurrence: ENEIDA registry data.

Time trends in strategies for postoperative Crohn's disease management and long-term surgical recurrence: ENEIDA registry data.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 05, 2026

Th1/Th17 cytokine signatures correlate with Crohn's disease activity in a 54‑week cohort of patients treated with adalimumab.

Th1/Th17 cytokine signatures correlate with Crohn's disease activity in a 54‑week cohort of patients treated with adalimumab.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 02, 2026

Factors Influencing Clinical and Radiological Response in Perianal Disease: Results from a Real-World Cohort Treated with Anti-TNF Therapy.

Factors Influencing Clinical and Radiological Response in Perianal Disease: Results from a Real-World Cohort Treated with Anti-TNF Therapy.

Journal: Journal of clinical medicine

Published: February 08, 2026

Usefulness of Nutritional Intervention Through New Digital Technologies in Patients with Inflammatory Bowel Disease.

Usefulness of Nutritional Intervention Through New Digital Technologies in Patients with Inflammatory Bowel Disease.

Journal: Nutrients

Published: February 02, 2026

Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry.

Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry.

Journal: United European gastroenterology journal

Published: February 01, 2026

Training satisfaction, competency gaps and well-being in gastroenterology residency in Spain: results of a national SEPD survey.

Training satisfaction, competency gaps and well-being in gastroenterology residency in Spain: results of a national SEPD survey.

Journal: BMC gastroenterology

Published: January 23, 2026

Post-Operative Recurrence of Colonic Crohn's Disease After Colectomy: The RESECOL Study by the Young Group of GETECCU.

Post-Operative Recurrence of Colonic Crohn's Disease After Colectomy: The RESECOL Study by the Young Group of GETECCU.

Journal: Alimentary pharmacology & therapeutics

Published: January 03, 2026

The TECCU-Based Telemonitoring Platform for Inflammatory Bowel Disease Is Cost-Effective: A Multicenter GETECCU Trial.

The TECCU-Based Telemonitoring Platform for Inflammatory Bowel Disease Is Cost-Effective: A Multicenter GETECCU Trial.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: December 13, 2025

T cell and cytokine signatures as early predictors of response to IL-12/IL-23 inhibition in Crohn's disease.

T cell and cytokine signatures as early predictors of response to IL-12/IL-23 inhibition in Crohn's disease.

Journal: Frontiers in immunology

Published: November 25, 2025

Showing 1-12 of 125

Last Updated: 09/26/2026